Philips Appoints Medical Director to the Board of MDIC, a Partnership Organization with the FDA
Carla Goulart Peron, Medical Director at Royal Philips, has been appointed to the board of directors of the Medical Device Innovation Consortium (MDIC), a public-private partnership organization founded in 2012.
Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the board of directors of the Medical Device Innovation Consortium. In her current role at Philips, she leads the global medical and scientific organization of the group and oversees the company's medical strategy. Dr. Peron has over 15 years of experience as a leader in the medical technology industry and healthcare sector.
Role of the Medical Device Innovation Consortium
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The Medical Device Innovation Consortium brings together stakeholders from the medical device sector with the U.S. Food and Drug Administration (FDA) and other government partners. The organization develops research, tools, and frameworks of action designed to assist manufacturers in navigating regulatory approval and in building the necessary evidence base for coverage decisions. The MDIC board includes officials from the medical device industry, patient advocates, as well as representatives from the FDA, the Centers for Medicare and Medicaid Services (CMS), and the National Institutes of Health (NIH).
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.